A company of visionaries
Meet our team and advisors
The management team
An experienced team combining business experience with technical expertise

Olivier Heyning
CEO

Andrea Candelli
CSO & Commercial Business Development

Gerrit Sitters
General Manager, Cell Avidity Business

Gijs Oude Elberink
COO

Geerte Hesen
Chief of Staff
Geerte brings significant global experience having most recently served as Deputy General Counsel at ASML and Head of Legal for the Philips Personal Health business. She brings significant experience in corporate law, commercial transactions, and compliance to LUMICKS.

Jos Maas
General Manager, Dynamic Single-Molecule Business
Jos brings a track record of growing high-tech businesses on a global scale and significant expertise in product marketing. Previously, he held several management positions at Nearfield Instruments, Thermo Fisher Scientific, Phenom-World (a spin-off from FEI Company), and ASML.
The board of directors
Seasoned business & life science experts advising us on strategy and key decisions

Don Kania (USA), Chair of the Board
Serves on the boards of Intuitive Surgical and Nanostring Technologies, as well as several non profit organizations. Former CEO at FEI (acquired by ThermoFisher), COO at Veeco. PhD in Physics & Engineering from University of Michigan.

Solange Bullukian (USA)
Strategic finance leader with experience in Fortune 500, scale-up and start-up organizations. Founder and Managing Principal of Scale2Growth. Previously CFO of Twist Bioscience, president, corporate controller, and CAO for Agilent Technologies, Board Member and Audit Committee Chair of Olink and Inari Agriculture.

Melissa McLaughlin (USA)
Chief People Officer at Agios Pharmaceuticals. Previously held positions as HR World Director at Johnson & Johnson, and Vice President, HR at Expedia. Currently advises Google Ventures‘ companies on HR strategy.

Alex Slack (USA)
Founding Partner of Lauxera Capital Partners. Former Managing Director on Maverick Capital‘s healthcare team, Analyst at Jackson Square Partners, and Management Consultant at McKinsey & Company.

Pieter van der Meer (NL)
Seasoned life science venture capitalist. Founder and managing partner of Gilde Healthcare.

Peter van den Broek (NL)
20 years of experience as a senior executive with General Electric and Danaher. Previously CEO of Leica and SVP at Fluke.

Olivier Heyning (NL)
Co-founder and CEO of LUMICKS. Previously Sales and Business Development Director at FEI – now Thermo Fisher Scientific.

Vali Barsan (USA)
Next generation sequencing engineer and oncologist at Stanford University School of Medicine. Dr. Barsan has led numerous life science investments in life science tools, molecular diagnostics, and next generation medicines at SoftBank. Serves on multiple boards including Umoja Biopharma, Neuron23, and ArsenalBio.
The board of directors
Seasoned business & life science experts advising us on strategy and key decisions
Don Kania (USA), Chair of the Board
Serves on the boards of Intuitive Surgical and Nanostring Technologies, as well as several non profit organizations. Former CEO at FEI (acquired by ThermoFisher), COO at Veeco. PhD in Physics & Engineering from University of Michigan.
Solange Glaize (USA)
Strategic finance leader with experience in Fortune 500, scale-up and start-up organizations. Previously CFO of Twist Bioscience, president, corporate controller, and CAO for Agilent Technologies, Board Member and Audit Committee Chair of Olink.
Melissa McLaughlin (USA)
Chief People Officer at Agios Pharmaceuticals. Previously held positions as HR World Director at Johnson & Johnson, and Vice President, HR at Expedia. Currently advises Google Ventures‘ companies on HR strategy.
Alex Slack (USA)
Founding Partner of Lauxera Capital Partners. Former Managing Director on Maverick Capital‘s healthcare team, Analyst at Jackson Square Partners, and Management Consultant at McKinsey & Company.
Pieter van der Meer (NL)
Seasoned life science venture capitalist. Founder and managing partner of Gilde Healthcare.
Peter van den Broek (NL)
20 years of experience as a senior executive with General Electric and Danaher. Previously CEO of Leica and SVP at Fluke.
Olivier Heyning (NL)
Co-founder and CEO of LUMICKS. Previously Sales and Business Development Director at FEI – now Thermo Fisher Scientific.
Vali Barsan (USA)
Next generation sequencing engineer and oncologist at Stanford University School of Medicine. Dr. Barsan has led numerous life science investments in life science tools, molecular diagnostics, and next generation medicines at SoftBank. Serves on multiple boards including Umoja Biopharma, Neuron23, and ArsenalBio.
The technical advisory board
The most knowledgeable people on our applications and technology

Dr. Michael Schnall-Levin (USA)
SVP R&D and founding scientist at 10x Genomics with extensive experience in successfully scaling up the company and bringing new products to market.

Prof.dr. Gijs Wuite (NL)
Biophysicist, PhD from UC Berkeley, single-molecule force spectroscopy and optical tweezers expert. Co-founded LUMICKS in 2014.

Prof.dr.ir. Erwin Peterman (NL)
Biophysicist, Post-doc Stanford University at W.E. Moerner (Nobel laureate 2014), single-molecule microscopy expert. Co-founded LUMICKS in 2014.

Dr. Sadik Kassim (USA)
Scientist and executive with extensive experience in the biotech industry and expert in cell and gene therapy. Currently, CTO at Danaher.
The technical advisory board
The most knowledgeable people on our applications and technology
Prof.dr. Gijs Wuite (NL)
Biophysicist, PhD from UC Berkeley, single-molecule force spectroscopy and optical tweezers expert. Co-founded LUMICKS in 2014.
Prof.dr.ir. Erwin Peterman (NL)
Biophysicist, Post-doc Stanford University at W.E. Moerner (Nobel laureate 2014), single-molecule microscopy expert. Co-founded LUMICKS in 2014.
Gigi Wang (US)
Global mentor for entrepreneurship and innovation. Managing Partner of MG-Team, LLC. Chair of Berkeley Method Boot-camp, Board Member MITEF/Stanford Venture Lab (VLAB).
Dr. John Rediske (US)
Project lead at Novartis in areas of immune therapies and oncology biologic therapeutics, Core team member workings towards registration of Kymriah. Obtained PhD in Immunology at Albany Medical College and Post Doc in inflammation at the University of Michigan.